Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.75 USD | -1.23% | -2.01% | +25.34% |
05-02 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
05-02 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |